Blair William & CO Ocugen, Inc. Transaction History
Blair William & CO
- $32 Billion
- Q2 2024
A detailed history of Blair William & CO transactions in Ocugen, Inc. stock. As of the latest transaction made, Blair William & CO holds 12,954 shares of OCGN stock, worth $15,674. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,954
Previous 12,954
-0.0%
Holding current value
$15,674
Previous $21,000
4.76%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding OCGN
# of Institutions
108Shares Held
66.5MCall Options Held
516KPut Options Held
272K-
Black Rock Inc. New York, NY17.9MShares$21.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$18.8 Million0.0% of portfolio
-
State Street Corp Boston, MA14.8MShares$17.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA5.9MShares$7.15 Million0.0% of portfolio
-
Rafferty Asset Management, LLC New York, NY1.08MShares$1.3 Million0.01% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $262M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...